Indegene IPO Description – Indegene is a commercialization company focused exclusively on the global life sciences industry. Its solutions enable biopharmaceutical, emerging biotech, and medical device companies to develop products, launch them in the market, and drive sales through their life cycle more effectively and efficiently. The company’s portfolio of solutions covers a broad range of commercial, medical, regulatory, and R&D operations of life sciences companies.
The company has relationships with each of the 20 largest biopharmaceutical companies globally by revenue for FY 2023. As of 31 December 2023, Indegene had a total of 65 active clients. It had 27 clients from whom it earned between USD 1 million and USD 10 million in revenues, five clients from whom it earned between USD 10 million and USD 25 million in revenues, and three clients from whom it earned more than USD 25 million in revenues, during the 12 months ended 31 December 2023.
Indegene has developed a suite of proprietary tools and platforms, including applications that automate and create AI-based efficiencies using AI, ML, NLP, and advanced analytics capabilities. These proprietary “NEXT”-branded tools and platforms assist in driving transformation across the commercialization lifecycle of biopharmaceutical products and medical devices.
Promoters of Indegene – The company is professionally managed and has no identifiable promoter
Table of Contents
Indegene IPO Details
| Indegene IPO Dates | 6 – 8 May 2024 |
| Indegene Issue Price | INR 430 – 452 per share Employee Discount – INR 30 per share |
| Fresh issue | 1,68,33,818 shares (INR 723.85 – 760 crore) |
| Offer For Sale | 2,39,32,732 shares (INR 1,081.76 crore) |
| Total IPO size | 4,07,66,550 shares (INR 1,752.96 – 1,841.76 crore) |
| Minimum bid (lot size) | 33 shares (INR 14,916) |
| Face Value | INR 2 per share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
Indegene Financial Performance
| FY 2021 | FY 2022 | FY 2023 | 9M FY 2024 | |
| Revenue | 966.27 | 1,664.61 | 2,306.13 | 1,916.61 |
| Expenses | 768.25 | 1,417.10 | 2,001.05 | 1,644.64 |
| Net income | 149.41 | 162.82 | 266.10 | 241.90 |
| Margin (%) | 15.46 | 9.78 | 11.54 | 12.62 |
Indegene Offer News
- Indegene IPO: 10 Points Investors Should Know
- Indegene RHP
- Indegene DRHP
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Indegene Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 (Pre Issue) | FY 2024 (Post-Issue)* | |
| EPS | 6.72 | 7.32 | 11.96 | 13.48 |
| PE Ratio | – | – | 35.94 – 37.78 | 31.90 – 33.53 |
| FY 2021 | FY 2022 | FY 2023 | |
| RONW (%) | 46.04 | 21.57 | 25.02 |
| NAV | 14.59 | 34.34 | 47.82 |
| Adjusted EBITDA (%) | 27.03 | 18.79 | 19.69 |
| Debt/Equity | – | – | 0.02 |
Indegene IPO GMP Today (Daily Trend)
| Date | Day-wise IPO GMP | Kostak | Subject to Sauda |
| 11 May 2024 | 270 | 1,300 | 5,800 |
| 10 May 2024 | 270 | 1,300 | 5,800 |
| 9 May 2024 | 275 | 1,300 | 5,500 |
| 8 May 2024 | 250 | 1,200 | 5,500 |
| 7 May 2024 | 250 | 1,200 | 5,500 |
| 6 May 2024 | 250 | 1,200 | 6,200 |
| 4 May 2024 | 230 | 1,300 | 5,800 |
| 3 May 2024 | 225 | 1,300 | 5,500 |
| 2 May 2024 | 225 | 1,300 | 5,700 |
| 1 May 2024 | 200 | 1,200 | 5,000 |
| 30 April 2024 | 160 | – | 1,200 |
| 29 April 2024 | 150 | – | – |
Indegene IPO Objectives
The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
- Repayment/prepayment of indebtedness of a subsidiary, ILSL Holdings – INR 391.34 crore
- Funding the capital expenditure requirements of the company and its subsidiary, Indegene, Inc. – INR 102.92 crore
- General corporate purposes
Indegene IPO Subscription – Live Updates
| Category | QIB | NII | Retail | Employee | Total |
|---|---|---|---|---|---|
| Shares Offered | 7,895,950 | 6,197,468 | 14,460,759 | 312,500 | 28,866,677 |
| 8 May 2024 | 197.55 | 54.63 | 7.58 | 6.20 | 69.63 |
| 7 May 2024 | 5.59 | 18.03 | 3.82 | 3.18 | 7.35 |
| 6 May 2024 | 0.05 | 4.14 | 1.50 | 1.31 | 1.67 |
Indegene IPO Allotment Status
Indegene IPO allotment status is now available on Link Intime’s website. Click on Link Intime IPO weblink to get allotment status.
Indegene IPO Dates & Listing Performance
| IPO Opening Date | 6 May 2024 |
| IPO Closing Date | 8 May 2024 |
| Finalization of Basis of Allotment | 9 May 2024 |
| Initiation of refunds | 10 May 2024 |
| Transfer of shares to demat accounts | 10 May 2024 |
| Indegene IPO Listing Date | 13 May 2024 |
| Opening Price on NSE | INR 655 per share (up 44.91%) |
| Closing Price on NSE | INR 570.90 per share (up 26.31%) |
Indegene IPO Reviews – Subscribe or Avoid?
Angel One –
Anand Rathi –
Axis Capital – Not Rated
Arihant Capital –
Ashika Research – Not Rated
BP Wealth – Subscribe
Capital Market – May Apply
Canara Bank Securities – Subscribe
Choice Broking –
Dalal & Broacha –
Elite Wealth – Not Rated
GCL Broking –
Geojit – Subscribe
GEPL Capital – Subscribe
Hem Securities – Subscribe
Hensex Securities – Subscribe
ICICIdirect –
Indsec – Subscribe
Jainam Broking – Subscribe for listing gain
DR Choksey –
LKP Research –
Marwadi Financial – Subscribe
Mehta Equities – Subscribe for long term
Motilal Oswal –
Nirmal Bang – Subscribe
Reliance Securities –
Religare Broking –
Samco Securities – Subscribe for long term
SBI Securities – Subscribe
SMC Global – 2.5/5
SMIFS Ltd – Subscribe
Sushil Finance – Apply for medium to long term
Swastika Investmart – Apply for long term
Ventura Securities – Subscribe
Indegene Offer Lead Manager
KOTAK MAHINDRA CAPITAL COMPANY LIMITED
27 BKC, 1st Floor, Plot no. C-27,
‘G’ Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051
Phone: +91 22 4336 0000
Email: [email protected]
Website: www.investmentbank.kotak.com
Indegene Offer Registrar
LINK INTIME INDIA PRIVATE LIMITED
C-101, 1st Floor, 247 Park L.B.S. Marg,
Vikhroli West, Mumbai – 400 083, Maharashtra
Telephone: +91 810 811 4949
Email: [email protected]
Website: www.linkintime.co.in
Indegene Contact Details
INDEGENE LIMITED
Aspen Block G4, 3rd Floor, Manyata Embassy Business Park,
Outer Ring Road, Nagawara, Bengaluru 560 045, Karnataka
Phone: +91 80 4674 4567
Email: [email protected]
Website: www.indegene.com
Indegene IPO FAQs
How many shares in Indegene IPO are reserved for HNIs and retail investors?
The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%.
How to apply for an Indegene Public Offer?
The best way to apply for Indegene’s public offer is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.
What is Indegene IPO GMP today?
Indegene IPO GMP today is INR 270 per share.
What is Indegene’s kostak rate today?
Indegene kostak rate today is INR 1,300 per application.
What is Indegene Subject to Sauda rate today?
Indegene Subject to Sauda rate today is INR 5,800 per application.
